Sentiss Pharma Private Limited

Sentiss Pharma Private Limited - healthcare in New Delhi, Delhi, India. FY 2026 financials and compliance.
CIN U74899DL1994PTC056894 Incorporated 13 January 1994 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹1,262.74 Cr
▲ 43.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹5.88 Cr
Issued & subscribed
Open charges
₹504.85 Cr
Satisfied ₹795.76 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
689
Latest available

About Sentiss Pharma Private Limited

Data last updated: 09 January 2026

Sentiss Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 13 January 1994, the company has been in operation for over 32 years.

Registered with ROC Delhi under CIN U74899DL1994PTC056894.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.88 Cr. Formerly known as Promed Exports Private Limited. It is led by directors including Canakapalli Bhaktavatasala Rao and Deepak Bahri.

Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: 212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016.

As per the financials filed for FY 2025, the company reported a revenue of ₹1,262.74 Cr, a growth of 43% compared to the previous year.

The company has a workforce of approximately 689 employees as per the latest available data.

The company is associated with 1 brand - Sentiss Pharma. As per MCA filings, the company has open charges of ₹504.85 Cr and satisfied charges of ₹795.76 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sentisspharma.com.

Company Details of Sentiss Pharma Private Limited
CIN U74899DL1994PTC056894
Registration Number 056894
Incorporation Date 13 January 1994
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Sentiss Pharma Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sentiss Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sentiss Pharma Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Sentiss Pharma Private Limited

Sentiss Pharma Private Limited operates one associated brand: Sentiss Pharma. These brands represent Sentiss Pharma Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Develops and manufactures ophthalmic, inhalational, ENT, and specialty drugs worldwide. sentisspharma.com

Competitors & Alternatives of Sentiss Pharma Private Limited

Brands and companies operating in the same space as Sentiss Pharma Private Limited include Annexon, Decibel Therapeutics, Alimera Sciences and 7 more.

Competitor Description Location Founded
Annexon Annexon Developer of antibodies to treat complement-mediated neurodegenerative diseases San Francisco, United States, United States 2011
Decibel Therapeutics Decibel Therapeutics Medicines are developed to protect, repair, and restore hearing capacity. Cambridge, United States, United States 2015
Alimera Sciences Alimera Sciences Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized. Alpharetta, United States, United States 2003
Lyra Therapeutics Lyra Therapeutics Small molecule therapeutics for ENT diseases are developed. Watertown, United States, United States 2005
MeiraGTx MeiraGTx Gene therapies for ocular and neurodegenerative diseases are developed. New York, United States, United States 2015
Aldeyra Aldeyra Drug candidates for immune-mediated diseases are developed by Aldeyra. Lexington, United States, United States 2004
Nicox Nicox Nitric oxide-based therapeutics for glaucoma and eye conditions are developed. Valbonne, France, France 1996
GenSight Biologics GenSight Biologics Viral vector-based gene therapies for retinal diseases are developed. Paris, France, France 2011
Kriya Therapeutics Kriya Therapeutics Developer of therapeutic solutions for the treatment of diabetes Redwood City, United States, United States 2012
Gyroscope Gyroscope Mobile SDK developed for app engagement and monetization strategies. San Francisco, United States, United States 2016

Business Activity of Sentiss Pharma Private Limited

Sentiss Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Sentiss Pharma Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Sentiss Pharma Private Limited

Sentiss Pharma Private Limited is audited by S.R. Batliboi & CO. LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
S.R. Batliboi & CO. LLP Locked Locked Locked
Premium access

Complete auditor history for Sentiss Pharma Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Sentiss Pharma Private Limited

Sentiss Pharma Private Limited is currently managed by 6 directors, with 15 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Canakapalli Bhaktavatasala Rao Director 29 Apr 2019 7 Years 3 Months Current
Deepak Bahri Managing Director 01 May 1995 31 Years 3 Months Current
Mahesh Kumar Garg Director 09 Jun 2015 11 Years 2 Months Current
Geeta Mathur Director 17 Jul 2017 9 Years 0 Months Current
Sameer Agarwal Director 10 Feb 2025 1 Years 6 Months Current
Deepak Kumar Khungar Director 21 Nov 2024 1 Years 8 Months Current

Financials of Sentiss Pharma Private Limited FY 2025 filings available

Sentiss Pharma Private Limited reported revenue of ₹1,262.74 Cr (up 43.00% YoY) for FY 2025.

Revenue · FY 2025
₹1,262.74 Cr ▲ 43.00%
Premium access

Ten-year financial statements for Sentiss Pharma Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Sentiss Pharma Private Limited

Premium access

Shareholding and ownership data for Sentiss Pharma Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Sentiss Pharma Private Limited

Open charges
₹504.85 Cr
Satisfied charges
₹795.76 Cr
Breakdown by lending institutions
Yes Bank Limited₹315.97 Cr
Others₹158.88 Cr
Hdfc Bank Limited₹30.00 Cr
Latest charge details
DateLenderAmountStatus
25 Nov 2025 Yes Bank Limited ₹230.97 Cr Open
15 Mar 2025 Others ₹20 Cr Open
26 Nov 2024 Others ₹54.88 Cr Open
28 Feb 2024 Hdfc Bank Limited ₹30 Cr Open
23 Sep 2023 Others ₹50 Cr Open

Total charge records: 33 View all charges

Employees and EPFO Compliance at Sentiss Pharma Private Limited

Sentiss Pharma Private Limited has a workforce of 689 employees as of Apr 06, 2024.

Employee count
689
Active EPFO establishments
2
Employee growth
3.3%
Premium access

Employee and EPFO history for Sentiss Pharma Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sentiss Pharma Private Limited

Premium access

GST registrations and filing compliance for Sentiss Pharma Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sentiss Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sentiss Pharma Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sentiss Pharma Private Limited

Premium access

MSME payment history for Sentiss Pharma Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sentiss Pharma Private Limited

Premium access

Corporate group structure for Sentiss Pharma Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sentiss Pharma Private Limited

Premium access

MCA filings and documents for Sentiss Pharma Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sentiss Pharma Private Limited

Charges
25 Nov 2025
A charge with Yes Bank Limited amounted to Rs. 230.97 Cr with Charge ID 101191596 was registered on 25 Nov 2025.
Charges
25 Nov 2025
A charge with Others of Rs. 54.88 Cr registered on 26 Nov 2024 with Charge ID 101006068 was modified on 25 Nov 2025.
Charges
25 Nov 2025
A charge with Yes Bank Limited of Rs. 85.00 Cr registered on 03 May 2018 with Charge ID 100185020 was modified on 25 Nov 2025.
Activity
29 Sep 2025
Sentiss Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
29 Aug 2025
A charge registered on 25 Jul 2024 via Charge ID 100959360 with Canara Bank was fully satisfied on 29 Aug 2025.
Activity
31 Mar 2025
Sentiss Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.

Frequently Asked Questions about Sentiss Pharma Private Limited

Sentiss Pharma Private Limited is an active private limited company in the healthcare sector based in New Delhi, Delhi, India. It was incorporated on 13 January 1994 (32+ years old) and is registered under CIN U74899DL1994PTC056894. The company has 689 employees.

Sentiss Pharma Private Limited reported revenue of ₹1,262.74 Cr for FY 2025 (up 43.00% YoY).

The current directors of Sentiss Pharma Private Limited are:

The primary industry of Sentiss Pharma Private Limited is healthcare. The company specifically operates in medical and laboratory equipment. The company is currently active in this sector.

Sentiss Pharma Private Limited can be reached at the registered office: 212 Ashirwad Commercialcomplex D – I Green Park, New Delhi, Delhi, India – 110016, or through the website sentisspharma.com.

The authorised capital is ₹10 Cr, and the paid-up capital is ₹5.88 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available